Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Resource Type
Article
Authors
Kulkarni, Prasad S. ; Padmapriyadarsini, Chandrasekaran ; Vekemans, Johan ; Bavdekar, Ashish ; Gupta, Madhu ; Kulkarni, Praveen ; Garg, B. S. ; Gogtay, Nithya J. ; Tambe, Muralidhar ; Lalwani, Sanjay ; Singh, Kiranjit ; Munshi, Renuka ; Meshram, Sushant ; Selvavinayagam, T. S. ; Pandey, Krishna ; Bhimarasetty, Devi Madhavi ; Ramakrishnan, S. R. ; Bhamare, Chetanraj ; Dharmadhikari, Abhijeet ; Budhawant, Chandrashekhar
Source
Human Vaccines & Immunotherapeutics; 2024, Vol. 20 Issue 1, p1-8, 8p
Subject
Language
ISSN
21645515